115 related articles for article (PubMed ID: 30655173)
1. Development of an auxotrophic, live-attenuated Brucella suis vaccine strain capable of expressing multimeric GnRH.
Smith GP; Jain-Gupta N; Alqublan H; Dorneles EMS; Boyle SM; Sriranganathan N
Vaccine; 2019 Feb; 37(7):910-914. PubMed ID: 30655173
[TBL] [Abstract][Full Text] [Related]
2. Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challenge.
Rajasekaran P; Surendran N; Seleem MN; Sriranganathan N; Schurig GG; Boyle SM
Vaccine; 2011 Apr; 29(17):3106-10. PubMed ID: 21376799
[TBL] [Abstract][Full Text] [Related]
3. Development of attenuated live vaccine candidates against swine brucellosis in a non-zoonotic B. suis biovar 2 background.
Aragón-Aranda B; de Miguel MJ; Lázaro-Antón L; Salvador-Bescós M; Zúñiga-Ripa A; Moriyón I; Iriarte M; Muñoz PM; Conde-Álvarez R
Vet Res; 2020 Jul; 51(1):92. PubMed ID: 32703299
[TBL] [Abstract][Full Text] [Related]
4. Brucella suis strain 2 vaccine is safe and protective against heterologous Brucella spp. infections.
Zhu L; Feng Y; Zhang G; Jiang H; Zhang Z; Wang N; Ding J; Suo X
Vaccine; 2016 Jan; 34(3):395-400. PubMed ID: 26626213
[TBL] [Abstract][Full Text] [Related]
5. Delta-pgm, a new live-attenuated vaccine against Brucella suis.
Czibener C; Del Giudice MG; Spera JM; Fulgenzi FR; Ugalde JE
Vaccine; 2016 Mar; 34(13):1524-1530. PubMed ID: 26899373
[TBL] [Abstract][Full Text] [Related]
6. Duplex PCR for differentiation of the vaccine strain Brucella suis S2 and B. suis biovar 1 from other strains of Brucella spp.
Nan W; Tan P; Wang Y; Xu Z; Mao K; Peng D; Chen Y
Vet J; 2014 Sep; 201(3):427-8. PubMed ID: 25011712
[TBL] [Abstract][Full Text] [Related]
7. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4.
Winter AJ; Schurig GG; Boyle SM; Sriranganathan N; Bevins JS; Enright FM; Elzer PH; Kopec JD
Am J Vet Res; 1996 May; 57(5):677-83. PubMed ID: 8723881
[TBL] [Abstract][Full Text] [Related]
8. Development and characterization of mouse models of infection with aerosolized Brucella melitensis and Brucella suis.
Smither SJ; Perkins SD; Davies C; Stagg AJ; Nelson M; Atkins HS
Clin Vaccine Immunol; 2009 May; 16(5):779-83. PubMed ID: 19321692
[TBL] [Abstract][Full Text] [Related]
9. Rough Brucella neotomae provides protection against Brucella suis challenge in mice.
Jain-Gupta N; Waldrop SG; Tenpenny NM; Witonsky SG; Boyle SM; Sriranganathan N
Vet Microbiol; 2019 Dec; 239():108447. PubMed ID: 31767087
[TBL] [Abstract][Full Text] [Related]
10. Development and evaluation of in murine model, of an improved live-vaccine candidate against brucellosis from to Brucella melitensis vjbR deletion mutant.
Li Z; Wang S; Zhang H; Xi L; Zhang J; Zhang X; Zhou Q; Yi J; Li M; Zhang W; Zhang J
Microb Pathog; 2018 Nov; 124():250-257. PubMed ID: 30149131
[TBL] [Abstract][Full Text] [Related]
11. Venezuelan field trials of vaccines against brucellosis in swine.
Lord VR; Cherwonogrodzky JW; Schurig GG; Lord RD; Marcano MJ; Meléndez GE
Am J Vet Res; 1998 May; 59(5):546-51. PubMed ID: 9582954
[TBL] [Abstract][Full Text] [Related]
12. A Brucella melitensis M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy.
Li ZQ; Shi JX; Fu WD; Zhang Y; Zhang J; Wang Z; Li TS; Chen CF; Guo F; Zhang H
Mol Immunol; 2015 Aug; 66(2):276-83. PubMed ID: 25899866
[TBL] [Abstract][Full Text] [Related]
13. Immune responses and protection induced by Brucella suis S2 bacterial ghosts in mice.
Liu J; Li Y; Sun Y; Ji X; Zhu L; Guo X; Zhou W; Zhou B; Liu S; Zhang R; Feng S
Vet Immunol Immunopathol; 2015 Aug; 166(3-4):138-44. PubMed ID: 26022514
[TBL] [Abstract][Full Text] [Related]
14. Use of serology and bacterial culture to determine prevalence of Brucella spp. In feral Swine (sus scrofa) in proximity to a beef cattle herd positive for Brucella suis and Brucella abortus.
Musser JM; Schwartz AL; Srinath I; Waldrup KA
J Wildl Dis; 2013 Apr; 49(2):215-20. PubMed ID: 23568896
[TBL] [Abstract][Full Text] [Related]
15. Identification of Brucella suis from feral swine in selected states in the USA.
Pedersen K; Quance CR; Robbe-Austerman S; Piaggio AJ; Bevins SN; Goldstein SM; Gaston WD; DeLiberto TJ
J Wildl Dis; 2014 Apr; 50(2):171-9. PubMed ID: 24484477
[TBL] [Abstract][Full Text] [Related]
16. Bioluminescence Imaging of Colonization and Clearance Dynamics of Brucella Suis Vaccine Strain S2 in Mice and Guinea Pigs.
Wang X; Li Z; Li B; Chi H; Li J; Fan H; Yao R; Li Q; Dong X; Chen M; Qu H; Wang Y; Gao W; Wang Y; Sun Y; Sun R; Qian J; Xia Z
Mol Imaging Biol; 2016 Aug; 18(4):519-26. PubMed ID: 26846129
[TBL] [Abstract][Full Text] [Related]
17. Research progress in live attenuated Brucella vaccine development.
Wang Z; Wu Q
Curr Pharm Biotechnol; 2013; 14(10):887-96. PubMed ID: 24372253
[TBL] [Abstract][Full Text] [Related]
18. Vaccination with a ΔnorD ΔznuA Brucella abortus mutant confers potent protection against virulent challenge.
Yang X; Clapp B; Thornburg T; Hoffman C; Pascual DW
Vaccine; 2016 Oct; 34(44):5290-5297. PubMed ID: 27639282
[TBL] [Abstract][Full Text] [Related]
19. Immunization of BALB/c mice with a combination of four recombinant Brucella abortus proteins, AspC, Dps, InpB and Ndk, confers a marked protection against a virulent strain of Brucella abortus.
Hop HT; Arayan LT; Huy TXN; Reyes AWB; Min W; Lee HJ; Park SJ; Chang HH; Kim S
Vaccine; 2018 May; 36(21):3027-3033. PubMed ID: 29678458
[TBL] [Abstract][Full Text] [Related]
20. Immunization of mice with a novel recombinant molecular chaperon confers protection against Brucella melitensis infection.
Ghasemi A; Jeddi-Tehrani M; Mautner J; Salari MH; Zarnani AH
Vaccine; 2014 Nov; 32(49):6659-66. PubMed ID: 25240754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
